Gastrointestinal symptoms are associated with hypothalamic-pituitary- adrenal axis suppression in healthy individuals

Scandinavian Journal of Gastroenterology

Volumn 42, Issue 11, 2007, Pages 1294-1301

  Karling, Pontus ^a   Norrback, Karl Fredrik ^a   Adolfsson, Rolf ^a   Danielsson, Åke ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Brain gut axis; Dexamethasone test; Gastrointestinal symptoms; HADS; HPA axis; Irritable bowel syndrome; S cortisol

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE;

ADULT; AGED; ANXIETY; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; DIARRHEA; DISEASE ASSOCIATION; FEMALE; GASTROINTESTINAL SYMPTOM; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IRRITABLE COLON; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; SATIETY;

ADULT; AGED; AGED, 80 AND OVER; ANXIETY; CORTICOTROPIN-RELEASING HORMONE; DEPRESSION; DEXAMETHASONE; FEMALE; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PITUITARY-ADRENAL SYSTEM; QUESTIONNAIRES;

EID: 35148880392     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520701395945     Document Type: Article

References (37)

1. Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJ III. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991;101:927-34.
2. Thompson WG, Irvine EJ, Pare P, Ferrazzi S, Rance L. Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci 2002;47:225-35.
3. Drossman DA, Camilleri M, Mayer E, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology 2002;123:2108-31.
4. Mayer EA, Craske M, Naliboff BD. Depression, anxiety, and the gastrointestinal system. J Clin Psychiatry 2001;62 Suppl 8:28-36.
5. Garakani A, Win T, Virk S, Gupta S, Kaplan D, Masand P. Comorbidity of irritable bowel syndrome in psychiatric patients: a review. Am J Ther 2003;10:61-7.
6. Claes SJ. CRH, stress, and major depression: a psychobiological interplay. Vitam Horm 2004;69:117-50.
7. APA Task Force on Laboratory Tests in Psychiatry. The dexamethasone suppression test: an overview of its current status in psychiatry. Am J Psychiatry 1987;144:1253-62.
8. Taché Y, Martinez V, Million M, Wang L. Stress and the gastrointestinal tract III. Stress-related alterations of gut motor function: role of brain corticotropin-releasing factor receptors. Am J Physiol Gastrointest Liver Physiol 2001;280:G173-7.
9. Fukudo S, Nomura T, Hongo M. Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and in patients with irritable bowel syndrome. Gut 1998;42:845-9.
10. Dinan TG, Quigley EMM, Ahmed SMM, Scully P, O'Brien S, O'Mahony L, et al. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology 2006;130:304-11.
11. Posserud I, Agerforz P, Ekman R, Bjornnson ES, Abrahamsson H, Simren M. Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress. Gut 2004;53:1102-8.
12. Groenink L, Dirks A, Verdouw PM, Schipholt M, Veening JG, van der Gugten J, et al. HPA axis dysregulation in mice overexpressing corticotrophin-releasing hormone. Biol Psychiatry 2002;51:875-81.
13. Nilsson L-G, Bäckman L, Erngrund K, Nyberg L, Adolfsson R, Bucht G, et al. The Betula prospective cohort study: memory, health, and aging. Aging Neuropsychol Cogn 1997;4:1-32.
14. Brändström S, Schlette P, Przybeck TR, Lundberg M, Forsgren T, Sigvardsson S, et al. Swedish normative data on personality using the temperament and character inventory. Compr Psychiatry 1998;39:122-8.
15. Chotai J, Forsgren T, Nilsson L-G, Adolfsson R. Season of birth variations in the temperament and character inventory of personality in a general population. Neuropsychobiology 2001;44:19-26.
16. Chotai J, Smedh K, Nilsson LG, Adolfsson R. A dual vulnerability hypothesis for seasonal depression is supported by the seasonal pattern assessment questionnaire in relation to the temperament and character inventory of personality in a general population. J Affect Disord 2004;82:61-70.
17. Rask E, Olsson T, Soderberg S, Andrew R, Livingstone DEW, Johnson O, et al. Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 2001;86:1418-21.
18. Wiklund IK, Fullerton S, Hawkey J, Jones RH, Longstreth F, Mayer EA, et al. An irritable bowel syndrome-specific symptom questionnaire: development and validation. Scand J Gastroenterol 2003;9:947-54.
19. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acute Psychiatr Scand 1983;67:361-70.
20. Herrmann C. International experience with the Hospital Anxiety and Depression Scale: a review of validation data and clinical results. J Psychosom Res 1997;42:17-41.
21. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An update literature review. J Psychosom Res 2002;52:69-77.
22. Salehi M, Ferenczi A, Zumoff B. Obesity and cortisol status. Horm Metab Res 2005;37:193-7.
23. Stratakis CA, Chrousos GP. Neuroendocrinology and pathophysiology of the stress system. Ann NY Acad Sci 1995;29;771:1-18.
24. Ising M, Kunzel HE, Binder EB, Nickel T, Modell S, Holsboer F. The combined dexamethasone/CRH test as a potential surrogate marker in depression [review]. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:1085-93.
25. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002;122:1140-56.
26. Ehlert U, Gaab J, Heinrichs M. Psychoneuroendocrinological contributions to the etiology of depression, posttraumatic stress disorder, and stress-related bodily disorders: the role of the hypothalamus-pituitary-adrenal axis. Biol Psychol 2001;57:141-52.
27. Böhmelt AH, Nater UM, Franke S, Hellhammer DH, Ehlert U. Basal and stimulated hypothalamic-pituitary-adrenal axis activity in patients with functional gastrointestinal disorders and healthy controls. Psychosom Med 2005;67:288-94.
28. Cleare AJ. The neuroendocrinology of chronic fatigue syndrome [review]. Endocr Rev 2003;24:236-52.
29. Heuser I, Yassouridis A, Holsboer F. The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. J Psychiatr Res 1994;28:341-56.
30. Patacchioli FR, Angelucci L, Dellerba G, Monnazzi P, Leri O. Actual stress, psychopathology and salivary cortisol levels in the irritable bowel syndrome. J Endocrinol Invest 2001;24:173-7.
31. Heitkamper M, Jarett M, Cain K, Shaver J, Bond E, Fugate Woods N, et al. Increased urine catecholamines and cortisol in women with irritable bowel syndrome. Am J Gastroenterol 1996;91:906-13.
32. Elsenbruch S, Thompson JJ, Hamish MJ, Exton MS, Orr WC. Behavioral and physiological sleep characteristics in women with irritable bowel syndrome. Am J Gastroenterol 2002;97:2306-14.
33. Elsenbruch S, Orr WC. Diarrhea- and constipation-predominant IBS patients differ in postprandial autonomic and cortisol responses. Am J Gastroenterol 2001;96:460-6.
34. Munakata J, Mayer EA, Chang L, Schmulson M, Liu M, Tougas G, et al. Autonomic and neuroendocrine responses to recto-sigmoid stimulation. Gastroenterology 1998;114:A808.
35. Sandler RS, Drossman DA, Nathan HP, McKee DC. Symptom complaints and health care seeking behaviour in subjects with bowel dysfunction. Gastroenterology 1984;87:314-8.
36. Koloski NA, Talley NJ, Boyce PM. Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia: a critical review of the literature on symptom and psychosocial factors. Am J Gastroenterol 2001;96:1340-9.
37. Dhillo WS, Kong WM, Le Roux CW, Alaghband-Zadeh J, Jones J, Carter G, et al. Cortisol-binding globulin is important in the interpretation of dynamic tests of the hypothalamic-pituitary-adrenal axis. Eur J Endocrinol 2002;146:231-5.